# Fluoroscopy Reduction or Elimination in CIED Implants

Study · id `cardio:ct-nct04919733` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04919733](<https://clinicaltrials.gov/study/NCT04919733>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04919733

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT04919733. Allocation not applicable; no masking; primary purpose treatment. Start 2020-01-03 (actual); primary completion 2024-01-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT04919733, source copy `cardio:ctgov-nct04919733-2022-05-26`, retrieved 2026-10-26)
- Started: 2020-01-03 (actual) (ClinicalTrials.gov record NCT04919733, source copy `cardio:ctgov-nct04919733-2022-05-26`, retrieved 2026-10-26)
- Primary completion: 2024-01-03 (anticipated) (ClinicalTrials.gov record NCT04919733, source copy `cardio:ctgov-nct04919733-2022-05-26`, retrieved 2026-10-26)
- Completion: 2024-03-03 (anticipated) (ClinicalTrials.gov record NCT04919733, source copy `cardio:ctgov-nct04919733-2022-05-26`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT04919733, source copy `cardio:ctgov-nct04919733-2022-05-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04919733-2022-05-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Fluoroscopy Reduction or Elimination in CIED Implants
- Condition: Bradycardia
- Condition: Tachycardia, Ventricular
- Condition: Heart Failure
- Intervention (Device): Fluoroscopy reduction
- Lead sponsor: Université de Sherbrooke
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Bradycardia (`cardio:bradycardia`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Université de Sherbrooke (`cardio:org-universite-de-sherbrooke`)

## Provenance

Content hash: 9bab3bcb42f3078c24a06648d38bfd5d7cf57be56e77ac129e9c46947a826048
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
